Patents/Assignees

89Bio, Inc.

4 patents in portfolio

US12350314utility2025
Liquid Formulations Comprising Mutant FGF-21 Peptide Pegylated Conjugates
0 cites
US12036284utility2024
Compositions and Methods of Treatment for Severe Hypertriglyceridemia
0 cites
US11850275utility2023
Liquid Formulations Comprising Mutant FGF-21 Peptide Pegylated Conjugates
0 cites
US11596669utility2023
Liquid Formulations Comprising Mutant FGF-21 Peptide Pegylated Conjugates
0 cites